Minimed Group Statistics
Total Valuation
Minimed Group has a market cap or net worth of $3.93 billion. The enterprise value is $3.99 billion.
Important Dates
The next estimated earnings date is Sunday, May 10, 2026, after market close.
| Earnings Date | May 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Minimed Group has 280.81 million shares outstanding.
| Current Share Class | 280.81M |
| Shares Outstanding | 280.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.03% |
| Float | 27.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 37.34 |
| PS Ratio | 1.36 |
| Forward PS | n/a |
| PB Ratio | 1.11 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 281.01 |
| PEG Ratio | 1.58 |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.38 |
| EV / EBITDA | 18.64 |
| EV / EBIT | 65.40 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.77 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 1.64% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $360,750 |
| Profits Per Employee | -$26,375 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Minimed Group has paid $72.00 million in taxes.
| Income Tax | 72.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 25.71 |
| Average Volume (20 Days) | 1,473,570 |
Short Selling Information
The latest short interest is 1.34 million, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.48% |
| Short % of Float | 4.79% |
| Short Ratio (days to cover) | 0.78 |
Income Statement
In the last 12 months, Minimed Group had revenue of $2.89 billion and -$211.00 million in losses.
| Revenue | 2.89B |
| Gross Profit | 1.64B |
| Operating Income | 61.00M |
| Pretax Income | -124.00M |
| Net Income | -211.00M |
| EBITDA | 214.00M |
| EBIT | 61.00M |
| Earnings Per Share (EPS) | n/a |
Full Income Statement Balance Sheet
The company has $8.00 million in cash and $63.00 million in debt, with a net cash position of -$55.00 million or -$0.20 per share.
| Cash & Cash Equivalents | 8.00M |
| Total Debt | 63.00M |
| Net Cash | -55.00M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 3.56B |
| Book Value Per Share | n/a |
| Working Capital | 431.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $14.00 million and capital expenditures -$221.00 million, giving a free cash flow of -$207.00 million.
| Operating Cash Flow | 14.00M |
| Capital Expenditures | -221.00M |
| Depreciation & Amortization | 153.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -207.00M |
| FCF Per Share | -$0.74 |
Full Cash Flow Statement Margins
Gross margin is 56.79%, with operating and profit margins of 2.11% and -7.31%.
| Gross Margin | 56.79% |
| Operating Margin | 2.11% |
| Pretax Margin | -4.30% |
| Profit Margin | -7.31% |
| EBITDA Margin | 7.42% |
| EBIT Margin | 2.11% |
| FCF Margin | n/a |
Dividends & Yields
Minimed Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.36% |
| FCF Yield | -5.26% |
Analyst Forecast
The average price target for Minimed Group is $22.56, which is 61.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.56 |
| Price Target Difference | 61.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |